The Drug Supply Chain Is Broken. A New Breakthrough Paves The Way For On-Demand Plant-Based Medicines
How A Newly Public Synthetic Biology Company Pivoted To The Pandemic: Up Close And Personal With Twist Bioscience
A Virtual Drug Discovery Company—With No Lab Of Its Own—Partners With Roche To Fight Cancers In The Brain
Can Technology Make More Natural Pesticides? Zymergen-FMC Partnership Offers A Peek Into The Future Of Crop Protection
More Talent Rushes To The Synthetic Biology Gold Mine: Venture Capitalist Mitchell Mutz Leaves Roche To Join Codon Capital
